AIDD
A methodological framework that applies artificial intelligence to pharmaceutical research and development, encompassing target identification, virtual screening, and molecular generation and optimization. It combines machine learning with medicinal chemistry expertise to accelerate new drug development workflows.
Timeline (last 90 days)
Key focus areas in AI-assisted drug discovery (AIDD) include target identification, virtual screening, molecular property prediction, activity prediction, ADMET prediction, and molecular generation and optimization, and practitioners will work with RDKit, molecular descriptors, machine learning, and graph neural networks.
QSAR (Quantitative Structure-Activity Relationship) establishes quantitative relationships between molecular structural features and biological activity through mathematical models, and is the most classical modeling paradigm in AIDD.
AIDD (AI-assisted drug discovery and development) is the direction with the highest salary ceiling in pharmaceutical AI, with primary work including target identification, virtual screening, and molecular generation and optimization.
Leading domestic pharmaceutical companies such as WuXi AppTec, Hengrui, and Innovent Biologics all have dedicated AIDD teams.
All Facts (4)
Key focus areas in AI-assisted drug discovery (AIDD) include target identification, virtual screening, molecular property prediction, activity prediction, ADMET prediction, and molecular generation and optimization, and practitioners will work with RDKit, molecular descriptors, machine learning, and graph neural networks.
50%UnverifiedQSAR (Quantitative Structure-Activity Relationship) establishes quantitative relationships between molecular structural features and biological activity through mathematical models, and is the most classical modeling paradigm in AIDD.
50%UnverifiedAIDD (AI-assisted drug discovery and development) is the direction with the highest salary ceiling in pharmaceutical AI, with primary work including target identification, virtual screening, and molecular generation and optimization.
50%UnverifiedLeading domestic pharmaceutical companies such as WuXi AppTec, Hengrui, and Innovent Biologics all have dedicated AIDD teams.
50%